— Know what they know.
Not Investment Advice
Also trades as: IFFT (NYSE) · $vol 6M

IFF NYSE

International Flavors & Fragrances Inc.
1W: -3.8% 1M: -5.2% 3M: -0.4% YTD: +21.2% 1Y: +36.0% 3Y: +29.0% 5Y: -30.1%
$82.42
-0.70 (-0.84%)
 
Weekly Expected Move ±2.4%
$79 $80 $82 $84 $86
NYSE · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 49 · $21.0B mcap · 255M float · 0.721% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.2 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 3.1%  ·  5Y Avg: -2.6%
Cost Advantage
33
Intangibles
89
Switching Cost
28
Network Effect
27
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IFF shows a Weak competitive edge (48.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 3.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$91
Low
$95
Avg Target
$100
High
Based on 5 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 25Hold: 8Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$95.00
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-07 Barclays — $90 $96 +6 +13.5% $84.55
2026-08-06 Robert W. Baird Ghansham Panjabi $90 $100 +10 +16.8% $85.61
2026-08-06 UBS Joshua Spector $75 $91 +16 +5.9% $85.92
2026-08-06 Oppenheimer — $90 $95 +5 +10.6% $85.87
2026-08-06 Vertical Research — Initiated $93 — +8.6% $85.63
2026-07-01 Morgan Stanley — $93 $95 +2 +18.7% $80.02
2026-05-07 Oppenheimer — $97 $90 -7 +8.5% $82.93
2026-05-07 Barclays Lauren Lieberman $80 $90 +10 +8.5% $82.93
2026-04-14 Barclays Lauren Lieberman $91 $80 -11 +11.0% $72.10
2026-04-09 UBS Joshua Spector $85 $75 -10 +2.6% $73.13
2026-02-17 Deutsche Bank — $100 $95 -5 +15.6% $82.18
2026-02-17 Mizuho Securities — $85 $92 +7 +10.8% $83.00
2026-02-13 Morgan Stanley Lisa De Neve $110 $93 -17 +12.8% $82.43
2026-02-13 Robert W. Baird — Initiated $90 — +9.2% $82.44
2026-02-13 UBS Joshua Spector $71 $85 +14 +4.0% $81.72
2026-02-13 Oppenheimer — $89 $97 +8 +19.5% $81.14
2026-02-13 Barclays — $78 $91 +13 +11.7% $81.50
2026-02-12 Mizuho Securities John Roberts $75 $85 +10 +10.4% $76.97
2026-01-22 Argus Research — $93 $80 -13 +9.9% $72.78
2026-01-16 Barclays Lauren Lieberman $82 $78 -4 +10.2% $70.78
2026-01-12 UBS — $66 $71 +5 +2.6% $69.23
2025-10-06 UBS Joshua Spector $100 $66 -34 +7.2% $61.59
2025-10-03 Mizuho Securities — $120 $75 -45 +21.9% $61.51
2025-08-07 Oppenheimer Kristen Owen $117 $89 -28 +38.6% $64.23
2025-03-27 Barclays Lauren Lieberman $75 $82 +7 +4.9% $78.18
2025-01-07 Argus Research Alexandra Yates $85 $93 +8 +12.6% $82.56
2024-11-11 Morgan Stanley Lisa De Neve $100 $110 +10 +20.6% $91.21
2024-10-24 Stifel Nicolaus Mark Astachan $115 $121 +6 +16.5% $103.88
2024-09-11 Oppenheimer Kristen Owen $116 $117 +1 +15.5% $101.28
2024-09-03 Mizuho Securities John Roberts $98 $120 +22 +15.4% $103.99
2024-07-22 Stifel Nicolaus Mark Astrachan $85 $115 +30 +20.2% $95.67
2024-07-09 UBS Joshua Spector Initiated $100 — +3.5% $96.64
2024-06-24 Jefferies Laurence Alexander $110 $111 +1 +13.1% $98.14
2024-06-06 Oppenheimer Kristen Owen Initiated $116 — +18.5% $97.90
2024-05-21 Morgan Stanley Lisa De Neve $90 $100 +10 +1.9% $98.09
2024-05-08 Jefferies Laurence Alexander $112 $110 -2 +13.1% $97.23
2024-05-07 Mizuho Securities John Roberts Initiated $98 — +10.5% $88.66
2024-04-12 Barclays Lauren Lieberman Initiated $75 — -13.4% $86.57
2024-04-04 Wells Fargo Michael Sison Initiated $100 — +17.0% $85.50
2024-03-20 Deutsche Bank David Begleiter Initiated $100 — +19.2% $83.92
2024-03-19 Stifel Nicolaus Mark Astachan $81 $85 +4 +2.3% $83.05
2024-01-21 Morgan Stanley Lisa De Neve $160 $90 -70 +12.8% $79.76
2024-01-11 Jefferies Laurence Alexander $180 $112 -68 +39.6% $80.25
2024-01-02 J.P. Morgan Jeffrey Zekauskas Initiated $67 — -17.3% $80.97
2023-11-28 Argus Research John Eade Initiated $85 — +12.3% $75.67
2023-09-18 Stifel Nicolaus Mark Astrachan $160 $81 -79 +19.0% $68.09
2022-01-24 Stifel Nicolaus Mark Astrachan Initiated $160 — +20.1% $133.19
2022-01-12 Jefferies Laurence Alexander Initiated $180 — +24.2% $144.97
2021-05-19 Citigroup PJ Juvekar Initiated $147 — +7.9% $136.21
2021-05-18 Societe Generale Thomas Swoboda Initiated $170 — +22.6% $138.69

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
3
ROE
3
ROA
5
D/E
1
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IFF receives an overall rating of B. Strongest factors: ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B- B
2026-08-05 B+ B-
2026-07-27 B B+
2026-07-02 B+ B
2026-05-28 B B+
2026-05-20 B+ B
2026-05-06 B- B+
2026-05-05 C B-
2026-02-18 C+ C
2026-02-17 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 39 Grade A
Profitability
23
Balance Sheet
50
Earnings Quality
75
Growth
46
Value
57
Momentum
78
Safety
30
Cash Flow
46
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IFF scores highest in Momentum (78/100) and lowest in Profitability (23/100). An overall grade of A places IFF among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.60
Distress Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✗
Beneish M-Score
-2.86
Unlikely Manipulator
Ohlson O-Score
-9.36
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB
Score: 44.3/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 4.00x
Accruals: -3.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IFF scores 1.60, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IFF scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IFF's score of -2.86 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IFF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IFF receives an estimated rating of BB (score: 44.3/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IFF's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
75.61x
PEG
1.23x
P/S
2.11x
P/B
1.51x
P/FCF
37.98x
P/OCF
17.54x
EV/EBITDA
17.52x
EV/Revenue
2.61x
EV/EBIT
48.39x
EV/FCF
48.57x
Earnings Yield
1.42%
FCF Yield
2.63%
Shareholder Yield
2.55%
Graham Number
$37.16
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 75.6x earnings, IFF is priced for high growth expectations. Graham's intrinsic value formula yields $37.16 per share, 122% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.826
NI / EBT
×
Interest Burden
0.652
EBT / EBIT
×
EBIT Margin
0.054
EBIT / Rev
×
Asset Turnover
0.389
Rev / Assets
×
Equity Multiplier
1.807
Assets / Equity
=
ROE
2.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IFF's ROE of 2.0% is driven by Asset Turnover (0.389), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$9.59
Price/Value
8.26x
Margin of Safety
-725.94%
Premium
725.94%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IFF's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. IFF trades at a 726% premium to its adjusted intrinsic value of $9.59, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 75.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$82.43
Median 1Y
$75.79
5th Pctile
$43.96
95th Pctile
$131.21
Ann. Volatility
33.7%
Analyst Target
$95.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
J. Erik Fyrwald
CEO
$1,026,250 $11,656,764 $15,002,866
Leticia Gonçalves Lourenço
President, Health & Biosciences
$566,667 $3,596,668 $5,809,059
Yuvraj Arora President,
Taste
$718,785 $3,199,672 $4,735,689
Jennifer Johnson EVP,
er EVP, General Counsel and Corporate Secretary
$349,153 $1,480,933 $4,004,838
Michael DeVeau Financial
ancial Officer
$700,000 $2,327,227 $3,708,475
Andres Muller President,
Food Ingredients
$615,750 $2,158,047 $3,613,343

CEO Pay Ratio

27:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $15,002,866
Avg Employee Cost (SGA/emp): $558,667
Employees: 3,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,000
-11.8% YoY
Revenue / Employee
$3,630,000
Rev: $10,890,000,000
Profit / Employee
$-124,667
NI: $-374,000,000
SGA / Employee
$558,667
Avg labor cost proxy
R&D / Employee
$231,333
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 1.8% 1.9% 2.6% 3.0% -9.2% -9.7% -11.0% -11.6% 0.1% -15.9% -15.6% -14.8% -14.6% 1.7% -6.1% -2.7% -2.8% -2.4% 6.2% 2.0% 2.04%
ROA 0.9% 1.0% 1.4% 1.6% -4.7% -5.0% -5.6% -6.0% 0.1% -7.7% -7.5% -7.3% -7.3% 0.8% -2.8% -1.4% -1.5% -1.2% 3.2% 1.1% 1.13%
ROIC 1.2% 1.4% 2.3% 2.6% -3.6% -3.6% -4.2% -4.5% 0.4% -6.7% -6.6% -6.7% -6.2% 3.0% -1.2% -1.3% -1.3% -1.4% 4.4% 3.1% 3.09%
ROCE 1.5% 1.8% 2.8% 3.1% -3.9% -4.1% -5.0% -5.2% 1.7% -8.0% -7.8% -7.6% -7.4% 2.4% -2.3% -0.9% -1.2% -0.7% 4.8% 2.6% 2.59%
Gross Margin 35.5% 32.4% 35.5% 34.4% 32.7% 30.6% 31.8% 31.9% 32.8% 31.8% 35.3% 37.0% 36.0% 35.4% 36.4% 37.3% 36.5% 34.4% 37.1% 43.7% 43.65%
Operating Margin 9.7% 5.7% 10.6% 6.4% -64.8% 3.7% 4.3% 5.0% 5.3% -93.8% 6.9% 6.6% 8.5% 4.6% -31.8% 7.2% 8.4% 4.4% 10.2% 8.1% 8.09%
Net Margin 6.3% 2.9% 7.6% 3.2% -71.7% -0.9% -0.3% 0.9% 0.9% -96.4% 2.1% 5.9% 2.0% -1.7% -35.8% 22.1% 1.5% 1.2% 6.2% 2.6% 2.56%
EBITDA Margin 20.2% 15.9% 20.5% 15.4% -54.2% 13.4% 12.9% 15.0% 15.6% -85.5% 16.4% 17.6% 14.3% 7.1% -24.2% 30.3% 13.0% 11.9% 18.2% 16.8% 16.79%
FCF Margin 11.2% 8.9% 5.1% 1.7% 0.0% -0.9% -0.2% 2.2% 3.9% 8.2% 8.5% 8.7% 8.1% 5.2% 5.0% 5.0% 3.0% 2.3% 3.7% 5.4% 5.37%
OCF Margin 14.4% 12.3% 8.7% 5.4% 4.0% 3.2% 4.3% 6.9% 8.6% 12.5% 12.4% 12.4% 11.8% 9.3% 9.6% 9.7% 8.1% 7.8% 9.1% 11.6% 11.64%
ROE 3Y Avg snapshot only -5.72%
ROE 5Y Avg snapshot only -5.31%
ROA 3Y Avg snapshot only -2.77%
ROIC 3Y Avg snapshot only -1.79%
ROIC Economic snapshot only 3.04%
Cash ROA snapshot only 4.62%
Cash ROIC snapshot only 5.91%
CROIC snapshot only 2.73%
NOPAT Margin snapshot only 6.09%
Pretax Margin snapshot only 3.52%
R&D / Revenue snapshot only 6.86%
SGA / Revenue snapshot only 17.58%
SBC / Revenue snapshot only 0.69%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 125.12 129.18 54.51 43.56 -12.05 -13.17 -10.27 -8.66 921.74 -7.73 -8.51 -10.04 -11.32 87.04 -23.37 -47.49 -38.15 -51.70 21.88 70.21 75.615
P/S Ratio 3.07 2.95 2.43 2.18 1.68 1.98 1.78 1.61 1.43 1.73 1.87 2.09 2.30 1.84 1.71 1.65 1.42 1.59 1.73 2.04 2.109
P/B Ratio 1.42 1.63 1.44 1.36 1.25 1.39 1.23 1.08 0.98 1.36 1.49 1.66 1.78 1.52 1.48 1.30 1.10 1.22 1.32 1.46 1.510
P/FCF 27.29 33.04 47.32 126.28 7055.00 -225.90 -1147.77 71.97 36.63 21.18 22.01 23.93 28.36 35.13 34.29 33.33 47.34 68.19 46.85 37.98 37.984
P/OCF 21.28 23.91 28.04 40.01 42.33 62.02 41.30 23.17 16.54 13.78 15.05 16.87 19.49 19.77 17.77 16.94 17.46 20.38 19.03 17.54 17.536
EV/EBITDA 27.78 25.49 19.01 17.54 -3560.89 -326.23 -87.27 -66.16 16.36 -28.74 -33.00 -37.28 -38.96 18.96 66.23 32.33 32.00 28.90 11.98 17.52 17.519
EV/Revenue 4.24 3.93 3.38 3.15 2.54 2.88 2.71 2.51 2.32 2.61 2.78 2.92 3.11 2.64 2.52 2.19 2.02 2.15 2.22 2.61 2.609
EV/EBIT 73.88 71.31 42.39 37.04 -26.68 -27.84 -21.65 -18.75 52.63 -13.71 -15.02 -16.61 -18.01 51.98 -53.55 -120.47 -82.72 -152.81 23.36 48.39 48.389
EV/FCF 37.76 44.09 65.82 182.67 10682.67 -329.22 -1745.35 112.35 59.60 31.99 32.69 33.47 38.33 50.34 50.63 44.10 67.27 92.05 60.05 48.57 48.570
Earnings Yield 0.8% 0.8% 1.8% 2.3% -8.3% -7.6% -9.7% -11.6% 0.1% -12.9% -11.7% -10.0% -8.8% 1.1% -4.3% -2.1% -2.6% -1.9% 4.6% 1.4% 1.42%
FCF Yield 3.7% 3.0% 2.1% 0.8% 0.0% -0.4% -0.1% 1.4% 2.7% 4.7% 4.5% 4.2% 3.5% 2.8% 2.9% 3.0% 2.1% 1.5% 2.1% 2.6% 2.63%
PEG Ratio snapshot only 1.226
Price/Tangible Book snapshot only 9.700
EV/OCF snapshot only 22.423
EV/Gross Profit snapshot only 6.953
Acquirers Multiple snapshot only 33.548
Shareholder Yield snapshot only 2.55%
Graham Number snapshot only $37.16
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.99 1.92 1.86 1.64 1.79 1.99 1.53 1.64 1.74 1.67 1.68 2.38 2.62 1.84 1.87 1.86 1.44 1.42 1.49 2.06 2.061
Quick Ratio 1.32 1.23 1.17 1.00 0.93 1.11 0.89 0.89 1.00 0.97 1.00 1.71 1.89 1.32 1.36 1.08 0.86 0.82 0.84 1.72 1.720
Debt/Equity 0.57 0.58 0.59 0.63 0.68 0.67 0.67 0.64 0.65 0.74 0.77 0.71 0.66 0.69 0.75 0.48 0.51 0.47 0.41 0.45 0.447
Net Debt/Equity 0.54 0.54 0.56 0.61 0.64 0.64 0.64 0.61 0.61 0.69 0.72 0.66 0.62 0.66 0.71 0.42 0.46 0.43 0.37 0.41 0.406
Debt/Assets 0.31 0.31 0.31 0.33 0.33 0.33 0.34 0.33 0.33 0.35 0.36 0.34 0.33 0.34 0.35 0.26 0.28 0.26 0.23 0.25 0.248
Debt/EBITDA 8.15 6.78 5.64 5.66 -1269.00 -106.77 -31.43 -25.20 6.69 -10.39 -11.55 -11.38 -10.76 6.02 22.78 8.97 10.37 8.22 2.92 4.20 4.201
Net Debt/EBITDA 7.70 6.39 5.34 5.41 -1209.22 -102.38 -29.88 -23.78 6.31 -9.71 -10.78 -10.63 -10.14 5.73 21.37 7.90 9.48 7.49 2.63 3.82 3.818
Interest Coverage 2.28 2.22 3.34 3.63 -3.94 -3.84 -4.21 -4.09 1.30 -6.54 -6.62 -6.74 -7.06 1.91 -1.84 -0.75 -1.08 -0.67 5.06 2.88 2.877
Equity Multiplier 1.88 1.88 1.90 1.94 2.05 2.01 2.00 1.96 1.97 2.12 2.14 2.07 2.03 2.07 2.15 1.81 1.81 1.80 1.78 1.80 1.800
Cash Ratio snapshot only 0.129
Debt Service Coverage snapshot only 7.947
Cash to Debt snapshot only 0.091
FCF to Debt snapshot only 0.086
Defensive Interval snapshot only 294.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.37 0.44 0.31 0.32 0.34 0.33 0.33 0.32 0.34 0.35 0.34 0.35 0.36 0.39 0.39 0.41 0.40 0.40 0.40 0.39 0.389
Inventory Turnover 3.73 4.34 3.08 3.04 3.03 2.85 2.81 2.73 2.72 2.63 2.68 2.84 2.94 3.01 2.95 3.00 3.02 3.01 2.89 3.11 3.110
Receivables Turnover 6.82 8.22 5.94 5.96 6.30 6.68 6.03 5.83 6.02 6.48 5.86 6.18 6.34 6.86 6.15 6.32 6.08 6.49 6.04 6.19 6.188
Payables Turnover 7.21 7.59 5.59 5.59 5.85 5.62 5.85 5.78 6.01 5.58 5.99 5.95 6.38 5.53 5.46 5.50 5.65 5.41 5.09 5.17 5.169
DSO 54 44 61 61 58 55 61 63 61 56 62 59 58 53 59 58 60 56 60 59 59.0 days
DIO 98 84 119 120 121 128 130 134 134 139 136 129 124 121 124 122 121 121 126 117 117.4 days
DPO 51 48 65 65 62 65 62 63 61 65 61 61 57 66 67 66 65 67 72 71 70.6 days
Cash Conversion Cycle 101 80 115 116 116 118 128 133 134 130 137 126 125 109 116 113 116 110 115 106 105.7 days
Fixed Asset Turnover snapshot only 3.122
Operating Cycle snapshot only 176.3 days
Cash Velocity snapshot only 17.536
Capital Intensity snapshot only 2.521
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 94.1% 1.3% 1.0% 56.1% 27.6% 6.7% -1.4% -6.1% -8.0% -7.7% -7.3% -4.7% -1.8% 0.0% 0.7% -0.1% -3.0% -5.2% -5.6% -11.7% -11.72%
Net Income -36.1% -26.2% 1.9% 3.7% -8.2% -8.0% -4.8% -4.5% 1.0% -37.1% -17.5% -6.8% -129.8% 1.1% 66.5% 83.3% 82.2% -2.4% 2.0% 1.7% 1.74%
EPS -71.4% -67.1% 1.3% 3.7% -8.2% -8.0% -4.8% -4.5% 1.0% -37.1% -17.1% -6.3% -129.3% 1.1% 66.5% 83.4% 82.2% -2.4% 2.0% 1.7% 1.74%
FCF 1.1% 99.1% -22.3% -76.5% -99.7% -1.1% -1.0% 21.6% 150.0% 9.6% 51.8% 2.7% 1.0% -35.7% -41.0% -43.3% -64.1% -57.8% -30.1% -4.3% -4.29%
EBITDA 63.3% 1.0% 1.5% 1.0% -1.0% -1.1% -1.2% -1.2% 184.3% -8.5% -1.5% -96.9% -1.6% 2.5% 1.5% 1.9% 1.8% -49.4% 3.6% 94.5% 94.50%
Op. Income -12.0% 3.2% 1.5% 1.8% -3.5% -3.3% -2.7% -2.6% 1.4% -59.1% -32.9% -24.4% -4.6% 1.4% 83.5% 83.5% 81.4% -1.5% 3.4% 3.4% 3.36%
OCF Growth snapshot only 5.35%
Asset Growth snapshot only -3.70%
Equity Growth snapshot only -2.97%
Debt Growth snapshot only -8.86%
Shares Change snapshot only 0.00%
Dividend Growth snapshot only 0.00%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 39.9% 43.1% 41.9% 38.9% 35.5% 34.3% 33.1% 32.5% 31.6% 31.2% 22.3% 11.8% 4.9% -0.5% -2.7% -3.6% -4.3% -4.3% -4.1% -5.6% -5.60%
Revenue 5Y 26.4% 30.2% 31.5% 31.5% 30.7% 29.6% 28.4% 27.1% 26.3% 23.6% 21.2% 19.1% 17.6% 17.4% 17.1% 17.3% 16.8% 16.5% 11.7% 4.3% 4.28%
EPS 3Y -35.1% -29.7% -8.1% -7.5% — — — — -72.4% — — — — -3.1% — — — — — — —
EPS 5Y -28.4% -27.1% -15.6% -13.0% — — — — -54.2% — — — — -25.1% — — — — 28.7% 16.4% 16.44%
Net Income 3Y -5.2% -7.6% 20.4% 21.4% — — — — -63.8% — — — — -3.0% — — — — — — —
Net Income 5Y -9.7% -8.1% 6.6% 9.8% — — — — -42.4% — — — — -11.9% — — — — 34.5% 16.6% 16.62%
EBITDA 3Y 27.2% 33.6% 40.3% 37.9% — — — — 21.3% — — — — -3.9% -41.8% -30.5% — — — — —
EBITDA 5Y 17.5% 21.5% 27.2% 28.0% — — — — 17.6% — — — — 9.4% -15.9% -4.7% -5.5% -2.1% 17.6% 6.0% 5.95%
Gross Profit 3Y 27.9% 30.4% 31.7% 30.6% 26.9% 25.2% 22.7% 21.8% 21.2% 20.8% 18.1% 12.8% 7.0% 3.4% 0.1% -2.0% -1.9% -1.7% -0.4% -0.2% -0.20%
Gross Profit 5Y 18.7% 21.7% 24.1% 25.3% 24.2% 23.0% 21.2% 19.5% 18.7% 16.9% 15.7% 14.7% 13.9% 14.3% 14.0% 14.5% 14.2% 13.6% 11.5% 6.7% 6.74%
Op. Income 3Y -5.9% 0.1% 17.2% 18.4% — — — — -3.1% — — — — 9.4% — — — — — — —
Op. Income 5Y -2.4% 0.5% 11.7% 14.6% — — — — -2.9% — — — — 2.9% — — — — 16.8% 16.3% 16.31%
FCF 3Y 66.9% 57.9% 28.8% -14.0% -80.1% — — -20.1% -5.2% 21.5% 5.6% 2.1% -5.9% -16.7% -3.7% 37.0% 3.8% — — 26.5% 26.47%
FCF 5Y 24.2% 19.8% 10.0% -6.4% -59.4% — — 2.2% 13.6% 28.8% 26.5% 23.6% 19.4% 5.7% 5.5% 1.5% -9.0% -13.4% -13.4% -10.4% -10.38%
OCF 3Y 53.6% 48.6% 29.4% 6.6% -6.9% -17.2% -7.6% 4.5% 11.1% 26.3% 10.2% 5.2% -1.9% -9.4% 0.7% 17.0% 21.6% 28.9% 22.9% 12.2% 12.15%
OCF 5Y 24.3% 21.3% 15.3% 9.7% 4.3% 0.3% 7.9% 16.2% 20.6% 26.9% 23.2% 19.8% 16.8% 8.9% 10.4% 8.8% 4.2% 3.5% -1.5% -0.7% -0.73%
Assets 3Y 61.2% 45.4% 44.4% 43.3% 38.6% 38.8% 40.9% 38.4% 36.7% 31.7% -9.1% -10.2% -9.4% -10.3% -10.7% -12.7% -9.3% -10.4% -10.8% -10.0% -9.96%
Assets 5Y 57.9% 58.1% 56.4% 53.5% 50.2% 50.5% 49.9% 49.1% 28.3% 19.2% 18.3% 17.2% 18.2% 16.6% 17.4% 15.0% 14.5% 13.5% -9.2% -9.2% -9.25%
Equity 3Y 74.5% 51.7% 50.5% 48.4% 40.8% 41.6% 45.0% 43.3% 40.8% 32.3% -12.9% -13.2% -11.7% -13.0% -14.3% -10.7% -5.5% -7.1% -7.4% -7.4% -7.44%
Book Value 3Y 19.4% 15.4% 14.9% 13.1% 7.5% 8.1% 10.5% 9.6% 7.5% 1.0% -19.0% -13.3% -11.9% -13.1% -14.4% -11.0% -5.8% -7.3% -7.6% -7.7% -7.68%
Dividend 3Y -18.1% -3.1% 2.5% -6.9% -13.2% -18.5% -22.8% -22.7% -23.0% -23.1% -6.5% -4.3% -9.4% -14.7% -21.0% -17.5% -13.1% -7.6% -0.3% -0.3% -0.26%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.71 0.64 0.71 0.80 0.83 0.80 0.83 0.87 0.86 0.77 0.75 0.75 0.72 0.60 0.52 0.49 0.48 0.49 0.46 0.23 0.232
Earnings Stability 0.37 0.08 0.05 0.06 0.47 0.43 0.37 0.36 0.26 0.73 0.67 0.65 0.54 0.23 0.47 0.34 0.22 0.03 0.00 0.01 0.010
Margin Stability 0.89 0.88 0.89 0.88 0.88 0.87 0.87 0.86 0.86 0.86 0.89 0.89 0.90 0.89 0.89 0.90 0.91 0.90 0.94 0.93 0.934
Rev. Growth Consistency 1.00 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.86 0.90 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.20 0.50 0.50 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness 0.56 0.70 0.04 0.00 — — — — — — — — — — — — — — — — —
ROE Trend -0.05 -0.05 -0.02 -0.01 -0.14 -0.14 -0.14 -0.14 0.05 -0.13 -0.13 -0.12 -0.11 0.16 0.08 0.12 0.05 0.06 0.18 0.12 0.117
Gross Margin Trend -0.08 -0.09 -0.06 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 0.00 0.01 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.023
FCF Margin Trend 0.02 -0.01 -0.06 -0.09 -0.11 -0.10 -0.09 -0.04 -0.02 0.04 0.06 0.07 0.06 0.02 0.01 -0.01 -0.03 -0.04 -0.03 -0.01 -0.015
Sustainable Growth Rate -2.2% -2.9% -1.1% -0.8% — — — — -4.8% — — — — -1.9% — — — — 3.2% -0.8% -0.84%
Internal Growth Rate — — — — — — — — — — — — — — — — — — 1.7% — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 5.88 5.40 1.94 1.09 -0.28 -0.21 -0.25 -0.37 55.72 -0.56 -0.57 -0.60 -0.58 4.40 -1.31 -2.80 -2.18 -2.54 1.15 4.00 4.003
FCF/OCF 0.78 0.72 0.59 0.32 0.01 -0.27 -0.04 0.32 0.45 0.65 0.68 0.70 0.69 0.56 0.52 0.51 0.37 0.30 0.41 0.46 0.462
FCF/Net Income snapshot only 1.848
OCF/EBITDA snapshot only 0.781
CapEx/Revenue 3.2% 3.4% 3.5% 3.7% 3.9% 4.1% 4.5% 4.7% 4.7% 4.4% 3.9% 3.7% 3.7% 4.1% 4.6% 4.8% 5.1% 5.5% 5.4% 6.3% 6.26%
CapEx/Depreciation snapshot only 0.659
Accruals Ratio -0.04 -0.04 -0.01 -0.00 -0.06 -0.06 -0.07 -0.08 -0.03 -0.12 -0.12 -0.12 -0.12 -0.03 -0.07 -0.05 -0.05 -0.04 -0.00 -0.03 -0.034
Sloan Accruals snapshot only 0.038
Cash Flow Adequacy snapshot only 1.123
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.8% 1.9% 2.6% 2.9% 3.8% 3.3% 3.7% 4.3% 5.0% 4.2% 3.9% 3.1% 2.4% 2.4% 2.1% 2.2% 2.6% 2.4% 2.2% 2.0% 1.94%
Dividend/Share $2.15 $2.62 $3.08 $3.12 $3.16 $3.18 $3.20 $3.22 $3.22 $3.24 $3.23 $2.82 $2.40 $2.01 $1.60 $1.59 $1.59 $1.59 $1.59 $1.59 $1.60
Payout Ratio 2.3% 2.5% 1.4% 1.3% — — — — 45.8% — — — — 2.1% — — — — 48.0% 1.4% 1.41%
FCF Payout Ratio 49.3% 64.1% 1.2% 3.6% 268.3% — — 3.1% 1.8% 88.2% 85.7% 73.2% 66.8% 85.4% 71.9% 73.0% 1.2% 1.6% 1.0% 76.3% 76.31%
Total Payout Ratio 2.3% 2.5% 1.4% 1.3% — — — — 45.8% — — — — 2.1% — — — — 59.3% 1.8% 1.79%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0
Chowder Number 0.73 1.09 1.45 0.85 0.51 0.25 0.07 0.08 0.07 0.06 0.05 -0.09 -0.23 -0.35 -0.48 -0.41 -0.31 -0.18 0.02 0.02 0.020
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.4% 0.5% 0.5% 0.54%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.4% 0.5% 0.5% 0.54%
Total Shareholder Return 1.8% 1.9% 2.6% 2.9% 3.8% 3.3% 3.7% 4.3% 5.0% 4.2% 3.9% 3.1% 2.4% 2.4% 2.1% 2.3% 2.7% 2.7% 2.7% 2.5% 2.55%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.76 0.75 0.80 0.81 1.17 1.15 1.12 1.11 0.15 1.02 1.03 1.03 1.03 0.87 1.00 0.82 0.79 0.88 1.04 0.83 0.826
Interest Burden (EBT/EBIT) 0.56 0.55 0.70 0.72 1.25 1.26 1.24 1.24 0.23 1.15 1.15 1.15 1.14 0.48 1.54 2.34 1.92 2.50 0.80 0.65 0.652
EBIT Margin 0.06 0.06 0.08 0.09 -0.10 -0.10 -0.13 -0.13 0.04 -0.19 -0.19 -0.18 -0.17 0.05 -0.05 -0.02 -0.02 -0.01 0.09 0.05 0.054
Asset Turnover 0.37 0.44 0.31 0.32 0.34 0.33 0.33 0.32 0.34 0.35 0.34 0.35 0.36 0.39 0.39 0.41 0.40 0.40 0.40 0.39 0.389
Equity Multiplier 1.94 1.94 1.89 1.91 1.95 1.94 1.94 1.95 2.01 2.06 2.06 2.01 1.99 2.09 2.14 1.94 1.92 1.93 1.96 1.81 1.807
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.95 $1.04 $2.17 $2.48 $-6.89 $-7.33 $-8.33 $-8.64 $0.07 $-10.05 $-9.75 $-9.19 $-9.02 $0.95 $-3.26 $-1.53 $-1.60 $-1.30 $3.32 $1.13 $1.13
Book Value/Share $84.02 $82.67 $82.09 $79.45 $66.22 $69.24 $69.64 $69.11 $66.32 $57.30 $55.82 $55.68 $57.49 $54.20 $51.47 $56.05 $55.41 $55.07 $54.94 $54.38 $54.72
Tangible Book/Share $-24.01 $-22.89 $-22.02 $-22.27 $-22.76 $-18.82 $-18.31 $-18.38 $-17.32 $-17.18 $-17.04 $-7.46 $-5.23 $-6.44 $-4.83 $-1.20 $-0.80 $-0.61 $0.13 $8.17 $8.17
Revenue/Share $38.80 $45.71 $48.69 $49.55 $49.52 $48.78 $48.00 $46.52 $45.39 $45.02 $44.34 $44.18 $44.42 $44.86 $44.64 $43.98 $43.08 $42.37 $41.98 $38.82 $38.98
FCF/Share $4.36 $4.08 $2.50 $0.85 $0.01 $-0.43 $-0.07 $1.04 $1.77 $3.67 $3.77 $3.86 $3.60 $2.35 $2.22 $2.18 $1.29 $0.99 $1.55 $2.09 $2.09
OCF/Share $5.59 $5.64 $4.22 $2.70 $1.96 $1.56 $2.07 $3.23 $3.92 $5.64 $5.51 $5.47 $5.24 $4.18 $4.29 $4.29 $3.50 $3.31 $3.81 $4.52 $4.54
Cash/Share $2.64 $2.79 $2.58 $2.23 $2.11 $1.89 $2.31 $2.50 $2.46 $2.76 $2.86 $2.62 $2.21 $1.83 $2.39 $3.18 $2.42 $2.30 $2.19 $2.21 $2.22
EBITDA/Share $5.92 $7.05 $8.65 $8.91 $-0.04 $-0.43 $-1.49 $-1.76 $6.45 $-4.09 $-3.73 $-3.46 $-3.54 $6.24 $1.70 $2.97 $2.72 $3.15 $7.76 $5.78 $5.78
Debt/Share $48.27 $47.84 $48.79 $50.44 $44.79 $46.06 $46.84 $44.47 $43.12 $42.44 $43.12 $39.40 $38.10 $37.58 $38.71 $26.65 $28.16 $25.88 $22.63 $24.29 $24.29
Net Debt/Share $45.64 $45.05 $46.22 $48.21 $42.68 $44.16 $44.53 $41.96 $40.66 $39.69 $40.27 $36.78 $35.89 $35.75 $36.32 $23.48 $25.75 $23.58 $20.45 $22.08 $22.08
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.597
Altman Z-Prime snapshot only 2.841
Piotroski F-Score 5 6 6 7 4 5 4 4 6 4 4 5 6 8 8 6 7 4 6 8 8
Beneish M-Score -1.24 -1.12 -2.61 -2.54 -2.77 -2.84 -2.92 -2.99 -2.71 -3.20 -3.25 -3.42 -3.32 -2.81 -3.01 -2.72 -2.70 -2.67 -2.44 -2.86 -2.863
Ohlson O-Score snapshot only -9.363
ROIC (Greenblatt) snapshot only 6.83%
Net-Net WC snapshot only $-8.00
EVA snapshot only $-1357022792.02
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 33.36 34.22 37.97 37.59 26.87 31.54 26.62 27.70 25.90 29.33 31.13 33.49 38.96 35.52 22.40 29.14 19.18 24.72 50.73 44.33 44.328
Credit Grade snapshot only 12
Credit Trend snapshot only 15.189
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 33

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms